pyridoxal phosphate has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bivalacqua, TJ; Champion, HC; De Witt, BJ; Inscho, EW; Kadowitz, PJ; Shah, MK | 1 |
| Diéguez, G; Fernández, N; García-Villalón, AL; Monge, L; Narváez-Sánchez, R; Salcedo, A | 1 |
2 other study(ies) available for pyridoxal phosphate and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Comparative responses to alpha,beta-methylene-ATP in cat pulmonary, mesenteric, and hindquarter vascular beds.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Angiotensin II; Animals; Blood Vessels; Cats; Dose-Response Relationship, Drug; Female; Hindlimb; Male; Mesenteric Arteries; Perfusion; Pressure; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Vasoconstrictor Agents | 2002 |
Coronary response to diadenosine pentaphosphate after ischaemia-reperfusion in the isolated rat heart.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Dinucleoside Phosphates; In Vitro Techniques; Male; Myocardial Reperfusion; NG-Nitroarginine Methyl Ester; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Vasoconstriction | 2009 |